Evidence map›Paper›PMID 40475015›Full record

ArticleFrontiers in oncology2025

Case Report: Primary leiomyosarcoma of the breast.

Haoqiang Lv, Haiyang Ren, Shuang Zhang, Gen Ding, Ping Tian

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haoqiang LvDepartment of General Surgery, Beidahuang Group Hongxinglong Hospital, Shuangyashan, Heilongjiang, China.
Haiyang RenDepartment of General Surgery, Linyi Maternity and Child Health Care Hospital, Linyi, Shandong, China.
Shuang ZhangDepartment of Pathology, Beidahuang Group Hongxinglong Hospital, Shuangyashan, Heilongjiang, China.
Gen DingDepartment of Medical Imaging, Linyi Maternity and Child Health Care Hospital, Linyi, Shandong, China.
Ping TianDepartment of Gastroenterology, Linyi People's Hospital, Linyi, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary leiomyosarcoma of the breast is an extremely rare tumor originating from the mesenchymal tissue of the breast. The clinical data of a case of primary leiomyosarcoma of the breast admitted to our hospital on September 11, 2024 were analyzed. A 58-year-old woman had a right breast mass for a week. Physical examination revealed an irregular mass at approximately 2-3 points in the right upper quadrant of the breast. Laboratory tests showed normal results for the tumor marker CA153. Color Doppler ultrasound considered solid nodules (BI-RADS Class 4b). Modified radical mastectomy and tertiary axillary lymph node dissection was performed on 2024-9-13, and the patient underwent adjuvant chemotherapy after surgery and recovered well. Pathological findings were reported one week after surgery: breast leiomyosarcoma. This article presents the diagnosis and treatment of primary leiomyosarcoma of breast through a clinical case, which provides a reference for clinicians. This case highlights the importance of pathological examination in the diagnosis of rare tumors, and suggests the need to combine imaging, laboratory examination and pathological findings to make a comprehensive judgment of breast masses.

Indexed as

breastbreast malignancymastectomyprimary leiomyosarcomasarcoma

Identifiers

PMID40475015
PMCPMC12137225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.